Hao Jiang

7PUBLICATIONS
25CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 11, 2026
Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial.

Bin Jiang, Jian Li, Ligen Liu

|Dec 01, 2025
Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insights.

Lin-Ya Wang, Hai-Tao Gao, Qiang Fu

|May 20, 2024
Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia.

Xiaolu Zhu, Feifei Tang, Wenjing Yu

|Apr 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

Fei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu

|Apr 24, 2023
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China.

Xiaolu Zhu, Qian Jiang, Jin Lu

|Mar 18, 2022
Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.

Jing Wang, Hao Jiang, Yu Jing

Pageof 2

Frequent Collaborators

4 joint publications

Qian Jiang

3 joint publications

Jinsong Jia

3 joint publications

Jing Wang

3 joint publications

Feifei Tang